Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Multiple Sclerosis Centers of Excellence

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge
 

Multiple Sclerosis Therapies

Treatments for MS focus on controlling the immune system and managing symptoms. The current goals for MS care are to reduce the frequency of relapses and to slow the progression of the disease by using a drug therapy approach called disease modifying treatments (DMTs). It is also important for people to work with their Health Care Providers to find the best approach to address MS symptoms like extreme fatigue, bladder problems and muscle spasms. MS symptoms can be managed with conventional medication, complementary and alternative medicine, physical therapy, mobility devices, and other self-care approaches. At this time, there is no cure for MS, but research continues to make great advancement in the understanding and treatment of this disease. Through the VA, Veterans have access to a multi-disciplinary team approach to treat MS.

Multiple Sclerosis Emerging Therapies Collaborative

The Multiple Sclerosis Emerging Therapies Collaborative is committed to developing and disseminating timely, evidence-based resources to persons affected by multiple sclerosis and health care professionals, in order to promote optimal, individualized treatment of the disease by facilitating effective communication and medical decision-making. 

Articles

Making the Decision to Use DMTs for Multiple Sclerosis
Monoclonal Antibody Treatment in MS
Multiple Sclerosis Treatments for Acute Attacks (Relapses)
Corticosteroids and Plasma Exchange Treatments for MS Acute Attacks
Monitoring for Cardiotoxicity in Patients with MS Post-Mitoxantrone Therapy: An Update

  

Updated: March 2016